PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20002521-3	2010	Rasagiline is primarily metabolized by hepatic cytochrome P-450 to form its major metabolite, 1-(R)-aminoindan, a non-amphetamine, weak reversible MAO-B inhibitor compound.	rasagiline	0-10	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	47-63	
17296539-7	2006	Rasagiline is almost completely eliminated by oxidative metabolism (catalyzed by cytochrome P-450 [CYP] isozyme 1A2) followed by renal excretion of conjugated parent compound and metabolites.	rasagiline	0-10	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	81-115	
27060436-2	2016	Rasagiline is metabolized by the cytochrome P450 (CYP) system, and the following three major metabolites with potential neuroprotective activity have been identified: 1-aminoindan (AI), 3-hydroxy-N-propargyl-1-aminoindan (3-OH-PAI) and 3-hydroxy-1-aminoindan (3-OH-AI).	rasagiline	0-10	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	33-48	
27060436-2	2016	Rasagiline is metabolized by the cytochrome P450 (CYP) system, and the following three major metabolites with potential neuroprotective activity have been identified: 1-aminoindan (AI), 3-hydroxy-N-propargyl-1-aminoindan (3-OH-PAI) and 3-hydroxy-1-aminoindan (3-OH-AI).	rasagiline	0-10	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	50-53